Elucidating the specific pharmacological mechanism of motion (MOA) of naturally occurring compounds is often tough. Whilst Tarselli et al. (sixty) formulated the first de novo synthetic pathway to conolidine and showcased this In a natural way occurring compound effectively suppresses responses to both equally chemically induced and inflammation-de